140 related articles for article (PubMed ID: 23641344)
1. An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres.
Dandagi PM; Belekar AM; Mastiholimath VS; Gadad AP; Sontake VW; Salian PS
Sci Pharm; 2013; 81(1):259-80. PubMed ID: 23641344
[TBL] [Abstract][Full Text] [Related]
2. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model.
Sensoy D; Cevher E; Sarici A; Yilmaz M; Ozdamar A; Bergişadi N
Eur J Pharm Biopharm; 2009 Aug; 72(3):487-95. PubMed ID: 19223014
[TBL] [Abstract][Full Text] [Related]
3. Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis.
Ch S; Mishra P; Bhatt H; Ghosh B; Roy S; Biswas S
Colloids Surf B Biointerfaces; 2021 Dec; 208():112113. PubMed ID: 34562784
[TBL] [Abstract][Full Text] [Related]
4. Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.
Mohan P; Kesavan K
AAPS PharmSciTech; 2021 Jun; 22(5):195. PubMed ID: 34184117
[TBL] [Abstract][Full Text] [Related]
5. Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach.
Majithiya RJ; Murthy RS
Curr Drug Deliv; 2005 Jul; 2(3):235-42. PubMed ID: 16305425
[TBL] [Abstract][Full Text] [Related]
6. Cationized gelatin-sodium alginate polyelectrolyte nanoparticles encapsulating moxifloxacin as an eye drop to treat bacterial keratitis.
Ch S; Paul M; Padaga SG; Ghosh B; Biswas S
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130457. PubMed ID: 38432265
[TBL] [Abstract][Full Text] [Related]
7. Cationic Chitosan/Pectin Polyelectrolyte Nanocapsules of Moxifloxacin as Novel Topical Management System for Bacterial Keratitis.
Mohan P; Rangari VD; Kesavan K
Curr Eye Res; 2022 Nov; 47(11):1498-1507. PubMed ID: 36099026
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
Patel JK; Chavda JR
J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro characterization of mucoadhesive hydroxypropyl guar microspheres containing amlodipine besylate for nasal administration.
Swamy NG; Abbas Z
Indian J Pharm Sci; 2011 Nov; 73(6):608-14. PubMed ID: 23112393
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effectiveness in the Treatment of Experimental Bacterial Keratitis with Ion-activated Mucoadhesive Hydrogel.
Kesavan K; Kant S; Pandit JK
Ocul Immunol Inflamm; 2016 Oct; 24(5):489-92. PubMed ID: 26133969
[TBL] [Abstract][Full Text] [Related]
11. Formulation and Evaluation of Propranolol Hydrochloride-Loaded Carbopol-934P/Ethyl Cellulose Mucoadhesive Microspheres.
Patel J; Patel D; Raval J
Iran J Pharm Res; 2010; 9(3):221-32. PubMed ID: 24363731
[TBL] [Abstract][Full Text] [Related]
12. Phase-transition W/O Microemulsions for Ocular Delivery: Evaluation of Antibacterial Activity in the Treatment of Bacterial Keratitis.
Bharti SK; Kesavan K
Ocul Immunol Inflamm; 2017 Aug; 25(4):463-474. PubMed ID: 26943481
[TBL] [Abstract][Full Text] [Related]
13. Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting.
Belgamwar VS; Patel HS; Joshi AS; Agrawal A; Surana SJ; Tekade AR
Drug Deliv; 2011 Jul; 18(5):353-60. PubMed ID: 21351825
[TBL] [Abstract][Full Text] [Related]
14. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
[TBL] [Abstract][Full Text] [Related]
15. Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats.
Kapanigowda UG; Nagaraja SH; Ramaiah B; Boggarapu PR
Daru; 2015 Oct; 23():49. PubMed ID: 26497653
[TBL] [Abstract][Full Text] [Related]
16. Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization,
Khan FU; Nasir F; Iqbal Z; Neau S; Khan I; Hassan M; Iqbal M; Ullah A; Khan SI; Sakhi M
Iran J Pharm Res; 2021; 20(3):592-608. PubMed ID: 34904011
[TBL] [Abstract][Full Text] [Related]
17. Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL.
Shastri DH; Prajapati ST; Patel LD
Curr Drug Deliv; 2010 Feb; ():. PubMed ID: 20158483
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of oral mucoadhesive multiparticulate system containing metoprolol tartarate: an in vitro-ex vivo characterization.
Belgamwar V; Shah V; Surana SJ
Curr Drug Deliv; 2009 Jan; 6(1):113-21. PubMed ID: 19418963
[TBL] [Abstract][Full Text] [Related]
19. Preparation and In Vitro/Ex Vivo Evaluation of Moxifloxacin-Loaded PLGA Nanosuspensions for Ophthalmic Application.
Mudgil M; Pawar PK
Sci Pharm; 2013; 81(2):591-606. PubMed ID: 23833723
[TBL] [Abstract][Full Text] [Related]
20. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
Patel JK; Patel MM
Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
